NR6A1
Nuclear receptor subfamily 6 group A member 1
Also known as: CT150, GCNF, GCNF1, NR6A1_HUMAN, RTR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15406
- Gene
- NR6A1
- Ensembl
- ENSG00000148200
- Chromosome
- 9
- Canonical length
- 480 aa
- Protein class
- Nuclear receptors, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Centrosome,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an orphan nuclear receptor which is a member of the nuclear hormone receptor family. Its expression pattern suggests that it may be involved in neurogenesis and germ cell development. The protein can homodimerize and bind DNA, but in vivo targets have not been identified. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Jun 2013]
Canonical amino-acid sequenceUniProt
480 residues, UniProt reviewed canonical sequence.
>Q15406|NR6A1
1 MERDEPPPSG GGGGGGSAGF LEPPAALPPP PRNGFCQDEL AELDPGTISV SDDRAEQRTC
61 LICGDRATGL HYGIISCEGC KGFFKRSICN KRVYRCSRDK NCVMSRKQRN RCQYCRLLKC
121 LQMGMNRKAI REDGMPGGRN KSIGPVQISE EEIERIMSGQ EFEEEANHWS NHGDSDHSSP
181 GNRASESNQP SPGSTLSSSR SVELNGFMAF REQYMGMSVP PHYQYIPHLF SYSGHSPLLP
241 QQARSLDPQS YSLIHQLLSA EDLEPLGTPM LIEDGYAVTQ AELFALLCRL ADELLFRQIA
301 WIKKLPFFCE LSIKDYTCLL SSTWQELILL SSLTVYSKQI FGELADVTAK YSPSDEELHR
361 FSDEGMEVIE RLIYLYHKFH QLKVSNEEYA CMKAINFLNQ DIRGLTSASQ LEQLNKRYWY
421 ICQDFTEYKY THQPNRFPDL MMCLPEIRYI AGKMVNVPLE QLPLLFKVVL HSCKTSVGKELocalizationUniProt · AlphaFold · HPA
Whether an antibody against NR6A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- testis: 21 nTPM
- thyroid gland: 5 nTPM
- bone marrow: 4.1 nTPM
- retina: 2.9 nTPM
- pancreas: 2.7 nTPM
- liver: 2.5 nTPM
Single-cell type
- choroid plexus epithelial cells: 1,018 nCPM
- sertoli cells: 925 nCPM
- retinal horizontal cells: 669 nCPM
- pituitary stem cells: 555 nCPM
- distal convoluted tubule cells: 474 nCPM
- neutrophils: 454 nCPM
Immune cell
- neutrophil: 4.8 nTPM
- eosinophil: 1.2 nTPM
- classical monocyte: 0.6 nTPM
- myeloid DC: 0.6 nTPM
- intermediate monocyte: 0.5 nTPM
- non-classical monocyte: 0.3 nTPM
Brain region
- choroid plexus: 12 nTPM
- hypothalamus: 9.5 nTPM
- cerebellum: 6.8 nTPM
- medulla oblongata: 6.8 nTPM
- basal ganglia: 6.1 nTPM
- cerebral cortex: 6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NR6A1.
Disease | AllUniProt
Conditions NR6A1 is implicated in, by any mechanism.
- Oculovertebral syndrome (OVS) MIM:621277
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 87 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Oculovertebral syndrome
- Isolated anophthalmia-microphthalmia syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 1.83
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- gamete generation
- negative regulation of transcription by RNA polymerase II
- positive regulation of mesenchymal stem cell differentiation
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity
- estrogen response element binding
- nuclear receptor activity
- protein homodimerization activity
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nuclear hormone receptor, ligand-binding domain
- Zinc finger, nuclear hormone receptor-type
- Nuclear hormone receptor
- Zinc finger, NHR/GATA-type
- Nuclear hormone receptor-like domain superfamily
- Nuclear hormone receptor family NR3 subfamily
- Ligand-binding domain of nuclear hormone receptor
- Double treble clef zinc finger, C4 type
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NR6A1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NR6A1 as an antibody target. Whether an autoantibody or antibody against NR6A1 could matter depends on whether native NR6A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NR6A1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NR6A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...